Income Taxes (Details) - USD ($) |
5 Months Ended | 7 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Dec. 31, 2024 |
Jul. 30, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Income Taxes | ||||
| Income tax benefit at federal statutory rate | 21.00% | 21.00% | 21.00% | |
| Income tax expense | $ (1,912,000) | $ 0 | $ 0 | |
| Valuation allowance to offset net deferred tax assets | 36,857,000 | 41,216,000 | 36,857,000 | |
| Net operating loss not subject to expiration | 104,000,000 | 104,000,000 | ||
| R & D tax credit | 1,604,000 | 1,604,000 | 1,604,000 | |
| Adagio Medical Inc | ||||
| Income Taxes | ||||
| Net operating loss carryforwards | 180,200 | 180,200 | ||
| Federal | ||||
| Income Taxes | ||||
| Net operating loss carryforwards | 122,900,000 | 151,700,000 | 122,900,000 | |
| Net operating loss subject to expiration | 19,000,000 | |||
| Net operating loss not subject to expiration | 132,700,000 | |||
| R & D tax credit | 1,600,000 | 1,600,000 | 1,600,000 | |
| State | ||||
| Income Taxes | ||||
| Net operating loss carryforwards | $ 53,400,000 | 53,400,000 | $ 53,400,000 | |
| Adagio Medical GmbH | ||||
| Income Taxes | ||||
| Net operating loss carryforwards | $ 245,100,000 | |||
| X | ||||||||||
- Definition Amount of operating loss carryforwards that are not subject to expiration dates. No definition available.
|
| X | ||||||||||
- Definition Amount of operating loss carryforwards that are subject to expiration dates. No definition available.
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|